Turning Discoveries into Treatments : Immunology in Africa
Copyright © 2020 Elsevier Ltd. All rights reserved..
An exemplar outcome of an immunology-based intervention is vaccine development; the current COVID-19 pandemic is a case in point. Can we build an immunology research ecosystem in Africa that nurtures discovery and enables translation? We see African immunologists as key agents of change and discuss obstacles and opportunities.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Trends in immunology - 41(2020), 12 vom: 01. Dez., Seite 1051-1053 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Osier, Faith H A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
African scientists |
|---|
| Anmerkungen: |
Date Completed 10.12.2020 Date Revised 23.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.it.2020.10.007 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317286226 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317286226 | ||
| 003 | DE-627 | ||
| 005 | 20231225162935.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.it.2020.10.007 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1057.xml |
| 035 | |a (DE-627)NLM317286226 | ||
| 035 | |a (NLM)33160840 | ||
| 035 | |a (PII)S1471-4906(20)30236-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Osier, Faith H A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Turning Discoveries into Treatments |b Immunology in Africa |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.12.2020 | ||
| 500 | |a Date Revised 23.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier Ltd. All rights reserved. | ||
| 520 | |a An exemplar outcome of an immunology-based intervention is vaccine development; the current COVID-19 pandemic is a case in point. Can we build an immunology research ecosystem in Africa that nurtures discovery and enables translation? We see African immunologists as key agents of change and discuss obstacles and opportunities | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a African scientists | |
| 650 | 4 | |a funding | |
| 650 | 4 | |a immunology | |
| 650 | 4 | |a training | |
| 650 | 4 | |a vaccines | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Mwandumba, Henry C |e verfasserin |4 aut | |
| 700 | 1 | |a Gray, Clive M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Trends in immunology |d 2001 |g 41(2020), 12 vom: 01. Dez., Seite 1051-1053 |w (DE-627)NLM111849063 |x 1471-4981 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2020 |g number:12 |g day:01 |g month:12 |g pages:1051-1053 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.it.2020.10.007 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2020 |e 12 |b 01 |c 12 |h 1051-1053 | ||